Tag: AbbVie

AbbVie Establish partnership with Frontier Medicines on protein degrader development

AbbVie, Harvard University Form Research Alliance to Address Emergent Viral Diseases

FDA Accepts sBLA for BOTOX® (onabotulinumtoxinA) for the Treatment of Pediatric Patients with Neurogenic Detrusor Overactivity

RINVOQ™Monotherapy Shows Improvement in Skin Clearance and Itch in First Phase 3 Study for Atopic Dermatitis

AbbVie and Genmab Announce Broad Oncology Collaboration

AbbVie Submits Regulatory Applications to FDA and EMA for RINVOQ™ for Psoriatic Arthritis

AbbVie and Jacobio Announce Strategic Collaboration to Advance SHP2 Inhibitors

AbbVie Presents New Data at the European E-Congress of Rheumatology 2020

AbbVie completes acquisition of Allergan

AbbVie Announces Extension of Expiration Date for Allergan Notes

Johnson & Johnson and AbbVie Receives 11th FDA Approval for IMBRUVICA® (ibrutinib)